Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

More on bacterial enzyme inhibitors under study at GlaxoSmithKline

Jan. 12, 2001

Inhibitors of p38 kinase and their use disclosed by Scios

Jan. 12, 2001

Recent patent covers new macrolides in development at Pfizer

Jan. 11, 2001

Preparation and use of cyclin-dependent kinase inhibitors

Jan. 11, 2001

Natural antihypertensive compound discovered in Brazilian plant

Jan. 11, 2001

Novel series from Pfizer for use in hyperproliferative conditions

Jan. 11, 2001

Scriptgen describes new antisickling agents identified using a novel method

Jan. 11, 2001

Gadolinium-based contrast agents for MRI patented by Guerbet

Jan. 11, 2001

Novel glucose uptake enhancers presented by Telik

Jan. 11, 2001

Bradycardic tetrahydroisoquinolines prepared by Yamanouchi research team

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...